Viewing Study NCT00366418


Ignite Creation Date: 2025-12-25 @ 4:55 AM
Ignite Modification Date: 2025-12-26 @ 3:55 AM
Study NCT ID: NCT00366418
Status: COMPLETED
Last Update Posted: 2017-07-02
First Post: 2006-08-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic Leukemia
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module